Latest filing published 25 May 2021 for Voyager Therapeutics, Inc., €12k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Omar Khwaja: trading record in brief
This profile gathers the share dealings of Omar Khwaja in Voyager Therapeutics, Inc., where the filings describe the role as chief executive. We count 7 filings; the first trade dates from 20 May 2019 and the latest from 21 May 2021.
Sales make up the whole of the open-market record (3 sales, €75k). Other entries cover 4 share grants. 2021 to date brings no purchases and 2 sales.
The newest entry dates from 25 May 2021: an open-market sale of €12k, in Voyager Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Omar Khwaja
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,516 shares@ US$4.03100.0% of flowCommon StockSEC:0001104659-21-071822:0
1 of 1 declaration
